Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 000413.SZ
Valuation Weak
28%
Profitability n.A.
Fin. Growth Bad
0%
Leverage & Liquidity Weak
17%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 0.28 0.90 0.90
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -40.30 -50.19 84.08
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -0.63 3.68 3.70
Cash 0.62 1.44 1.44
Capex 69.82 < 0.005 -0.02
Free Cash Flow 69.82 < 0.005 -0.02
Revenue -7.84 0.18 0.20
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -87.85 0.05 0.37
Operating Margin 78.49 -0.29 -1.34
ROA 76.36 < 0.005 -0.02
ROE 75.82 -0.01 -0.06
ROIC 76.02 < 0.005 -0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 000413.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 000413.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 000413.SZ is permitted for members.